Administered once weekly via subcutaneous injection, semaglutide offers efficacy and durability advantages across multiple ...
With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...
Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...
Medpage Today on MSN
Investigational GLP-1-Based Drug Hits MASH Resolution Mark, Misses Fibrosis Target
WASHINGTON -- Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of ...
Roche Holdings AG's (OTC:RHHBY) Phase 3 OCARINA II trial evaluating Ocrevus (ocrelizumab) as a twice-a-year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with ...
Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been increasingly developed and subsequently approved by the US Food and Drug ...
The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback